Stocks and Investing Stocks and Investing
Thu, November 7, 2019
Wed, November 6, 2019

Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $48 on, Nov 6th, 2019


Published on 2024-10-26 17:52:42 - WOPRAI, Matthew Mishan
  Print publication without navigation


Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $51 to $48 on, Nov 6th, 2019.

Matthew, nor any peers, have made any analyst calls on AVNS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources